Laboratory of Medicinal Chemistry, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
Medifron DBT, Seoul 08502, Republic of Korea.
Bioorg Med Chem Lett. 2020 Dec 1;30(23):127548. doi: 10.1016/j.bmcl.2020.127548. Epub 2020 Sep 12.
A series of 1-indazol-3-(1-phenylpyrazol-5-yl)methyl ureas were investigated as hTRPV1 antagonists. The structure-activity relationship study was conducted systematically for both the indazole A-region and the 3-trifluoromethyl/t-butyl pyrazole C-region to optimize the antagonism toward the activation by capsaicin. Among them, the antagonists 26, 50 and 51 displayed highly potent antagonism with K = 0.4-0.5 nM. Further, in vivo studies in mice indicated that these derivatives both antagonized capsaicin induced hypothermia, consistent with their in vitro activity, and themselves did not induce hyperthermia. In the formalin model, 51 showed anti-nociceptive activity in a dose-dependent manner.
一系列 1-吲唑-3-(1-苯基吡唑-5-基)甲基脲被研究为 TRPV1 拮抗剂。我们系统地进行了吲唑 A 区域和 3-三氟甲基/叔丁基吡唑 C 区域的构效关系研究,以优化对辣椒素激活的拮抗作用。其中,拮抗剂 26、50 和 51 对辣椒素诱导的降温表现出高度有效的拮抗作用,其 K 值为 0.4-0.5 nM。此外,在小鼠体内研究中,这些衍生物均拮抗辣椒素诱导的体温过低,与其体外活性一致,且自身不引起体温过高。在福马林模型中,51 以剂量依赖性方式表现出镇痛活性。